tiprankstipranks
Insmed (INSM)
NASDAQ:INSM
Want to see INSM full AI Analyst Report?

Compare Insmed (INSM) vs. Competitors

1,112 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Insmed
$144.48
$22.66B
-53.85
53.78%
17 Buy
0 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$54.64
$10.46B
25.76
-8.77%
14 Buy
4 Hold
0 Sell
Strong Buy
Incyte
$97.82
$19.53B
15.46
64.18%
8 Buy
10 Hold
1 Sell
Moderate Buy
Genmab
$28.55
$16.49B
153.52
31.36%
8 Buy
2 Hold
0 Sell
Strong Buy
BioNTech SE
$102.92
$23.52B
-8.99
0.24%
14 Buy
1 Hold
0 Sell
Strong Buy
Royalty Pharma
$50.00
$28.96B
53.28%
7 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INSM
Insmed
105.00
39.92
61.34%
BMRN
BioMarin Pharmaceutical
54.12
-4.74
-8.05%
INCY
Incyte
97.77
38.79
65.77%
GMAB
Genmab
27.06
7.70
39.77%
BNTX
BioNTech SE
93.02
0.25
0.27%
RPRX
Royalty Pharma
50.20
17.82
55.03%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts